132 related articles for article (PubMed ID: 15056000)
1. Structure-based design of potent retinoid X receptor alpha agonists.
Haffner CD; Lenhard JM; Miller AB; McDougald DL; Dwornik K; Ittoop OR; Gampe RT; Xu HE; Blanchard S; Montana VG; Consler TG; Bledsoe RK; Ayscue A; Croom D
J Med Chem; 2004 Apr; 47(8):2010-29. PubMed ID: 15056000
[TBL] [Abstract][Full Text] [Related]
2. N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents.
Henke BR; Blanchard SG; Brackeen MF; Brown KK; Cobb JE; Collins JL; Harrington WW; Hashim MA; Hull-Ryde EA; Kaldor I; Kliewer SA; Lake DH; Leesnitzer LM; Lehmann JM; Lenhard JM; Orband-Miller LA; Miller JF; Mook RA; Noble SA; Oliver W; Parks DJ; Plunket KD; Szewczyk JR; Willson TM
J Med Chem; 1998 Dec; 41(25):5020-36. PubMed ID: 9836620
[TBL] [Abstract][Full Text] [Related]
3. Novel (2E,4E,6Z)-7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta-2,4,6-trienoic acid retinoid X receptor modulators are active in models of type 2 diabetes.
Michellys PY; Ardecky RJ; Chen JH; Crombie DL; Etgen GJ; Faul MM; Faulkner AL; Grese TA; Heyman RA; Karanewsky DS; Klausing K; Leibowitz MD; Liu S; Mais DA; Mapes CM; Marschke KB; Reifel-Miller A; Ogilvie KM; Rungta D; Thompson AW; Tyhonas JS; Boehm MF
J Med Chem; 2003 Jun; 46(13):2683-96. PubMed ID: 12801232
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and structure-activity relationship studies of novel 6,7-locked-[7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta]-2,4,6-trienoic acids.
Michellys PY; Ardecky RJ; Chen JH; D'Arrigo J; Grese TA; Karanewsky DS; Leibowitz MD; Liu S; Mais DA; Mapes CM; Montrose-Rafizadeh C; Ogilvie KM; Reifel-Miller A; Rungta D; Thompson AW; Tyhonas JS; Boehm MF
J Med Chem; 2003 Sep; 46(19):4087-103. PubMed ID: 12954061
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of alpha-aryloxy-alpha-methylhydrocinnamic acids: a novel class of dual peroxisome proliferator-activated receptor alpha/gamma agonists.
Xu Y; Rito CJ; Etgen GJ; Ardecky RJ; Bean JS; Bensch WR; Bosley JR; Broderick CL; Brooks DA; Dominianni SJ; Hahn PJ; Liu S; Mais DE; Montrose-Rafizadeh C; Ogilvie KM; Oldham BA; Peters M; Rungta DK; Shuker AJ; Stephenson GA; Tripp AE; Wilson SB; Winneroski LL; Zink R; Kauffman RF; McCarthy JR
J Med Chem; 2004 May; 47(10):2422-5. PubMed ID: 15115385
[TBL] [Abstract][Full Text] [Related]
6. RXR receptor agonist suppression of thyroid function: central effects in the absence of thyroid hormone receptor.
Macchia PE; Jiang P; Yuan YD; Chandarardna RA; Weiss RE; Chassande O; Samarut J; Refetoff S; Burant CF
Am J Physiol Endocrinol Metab; 2002 Aug; 283(2):E326-31. PubMed ID: 12110538
[TBL] [Abstract][Full Text] [Related]
7. Enantioselective syntheses of potent retinoid X receptor ligands: differential biological activities of individual antipodes.
Vuligonda V; Thacher SM; Chandraratna RA
J Med Chem; 2001 Jul; 44(14):2298-303. PubMed ID: 11428923
[TBL] [Abstract][Full Text] [Related]
8. N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituent.
Cobb JE; Blanchard SG; Boswell EG; Brown KK; Charifson PS; Cooper JP; Collins JL; Dezube M; Henke BR; Hull-Ryde EA; Lake DH; Lenhard JM; Oliver W; Oplinger J; Pentti M; Parks DJ; Plunket KD; Tong WQ
J Med Chem; 1998 Dec; 41(25):5055-69. PubMed ID: 9836622
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of alpha-aryloxyphenylacetic acid derivatives: a novel class of PPARalpha/gamma dual agonists with potent antihyperglycemic and lipid modulating activity.
Shi GQ; Dropinski JF; McKeever BM; Xu S; Becker JW; Berger JP; MacNaul KL; Elbrecht A; Zhou G; Doebber TW; Wang P; Chao YS; Forrest M; Heck JV; Moller DE; Jones AB
J Med Chem; 2005 Jun; 48(13):4457-68. PubMed ID: 15974597
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of retinoid X receptor-specific ligands that are potent inducers of adipogenesis in 3T3-L1 cells.
Canan Koch SS; Dardashti LJ; Cesario RM; Croston GE; Boehm MF; Heyman RA; Nadzan AM
J Med Chem; 1999 Feb; 42(4):742-50. PubMed ID: 10052980
[TBL] [Abstract][Full Text] [Related]
11. N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 2. Structure-activity relationship and optimization of the phenyl alkyl ether moiety.
Collins JL; Blanchard SG; Boswell GE; Charifson PS; Cobb JE; Henke BR; Hull-Ryde EA; Kazmierski WM; Lake DH; Leesnitzer LM; Lehmann J; Lenhard JM; Orband-Miller LA; Gray-Nunez Y; Parks DJ; Plunkett KD; Tong WQ
J Med Chem; 1998 Dec; 41(25):5037-54. PubMed ID: 9836621
[TBL] [Abstract][Full Text] [Related]
12. (2R)-2-ethylchromane-2-carboxylic acids: discovery of novel PPARalpha/gamma dual agonists as antihyperglycemic and hypolipidemic agents.
Koyama H; Miller DJ; Boueres JK; Desai RC; Jones AB; Berger JP; MacNaul KL; Kelly LJ; Doebber TW; Wu MS; Zhou G; Wang PR; Ippolito MC; Chao YS; Agrawal AK; Franklin R; Heck JV; Wright SD; Moller DE; Sahoo SP
J Med Chem; 2004 Jun; 47(12):3255-63. PubMed ID: 15163205
[TBL] [Abstract][Full Text] [Related]
13. Syntheses and structure-activity relationships of novel retinoid X receptor agonists.
Hibi S; Kikuchi K; Yoshimura H; Nagai M; Tai K; Hida T
J Med Chem; 1998 Aug; 41(17):3245-52. PubMed ID: 9703470
[TBL] [Abstract][Full Text] [Related]
14. Indanylacetic acid derivatives carrying 4-thiazolyl-phenoxy tail groups, a new class of potent PPAR alpha/gamma/delta pan agonists: synthesis, structure-activity relationship, and in vivo efficacy.
Rudolph J; Chen L; Majumdar D; Bullock WH; Burns M; Claus T; Dela Cruz FE; Daly M; Ehrgott FJ; Johnson JS; Livingston JN; Schoenleber RW; Shapiro J; Yang L; Tsutsumi M; Ma X
J Med Chem; 2007 Mar; 50(5):984-1000. PubMed ID: 17274610
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a novel series of peroxisome proliferator-activated receptor alpha/gamma dual agonists for the treatment of type 2 diabetes and dyslipidemia.
Liu K; Xu L; Berger JP; Macnaul KL; Zhou G; Doebber TW; Forrest MJ; Moller DE; Jones AB
J Med Chem; 2005 Apr; 48(7):2262-5. PubMed ID: 15801817
[TBL] [Abstract][Full Text] [Related]
16. 2-amino-1,3-thiazol-4(5H)-ones as potent and selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitors: enzyme-ligand co-crystal structure and demonstration of pharmacodynamic effects in C57Bl/6 mice.
Johansson L; Fotsch C; Bartberger MD; Castro VM; Chen M; Emery M; Gustafsson S; Hale C; Hickman D; Homan E; Jordan SR; Komorowski R; Li A; McRae K; Moniz G; Matsumoto G; Orihuela C; Palm G; Veniant M; Wang M; Williams M; Zhang J
J Med Chem; 2008 May; 51(10):2933-43. PubMed ID: 18419108
[TBL] [Abstract][Full Text] [Related]
17. Large dimeric ligands with favorable pharmacokinetic properties and peroxisome proliferator-activated receptor agonist activity in vitro and in vivo.
Sauerberg P; Bury PS; Mogensen JP; Deussen HJ; Pettersson I; Fleckner J; Nehlin J; Frederiksen KS; Albrektsen T; Din N; Svensson LA; Ynddal L; Wulff EM; Jeppesen L
J Med Chem; 2003 Nov; 46(23):4883-94. PubMed ID: 14584939
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a novel selective PPARgamma modulator from (-)-Cercosporamide derivatives.
Furukawa A; Arita T; Satoh S; Wakabayashi K; Hayashi S; Matsui Y; Araki K; Kuroha M; Ohsumi J
Bioorg Med Chem Lett; 2010 Apr; 20(7):2095-8. PubMed ID: 20219371
[TBL] [Abstract][Full Text] [Related]
19. Discovery of a series of imidazo[4,5-b]pyridines with dual activity at angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-γ.
Casimiro-Garcia A; Filzen GF; Flynn D; Bigge CF; Chen J; Davis JA; Dudley DA; Edmunds JJ; Esmaeil N; Geyer A; Heemstra RJ; Jalaie M; Ohren JF; Ostroski R; Ellis T; Schaum RP; Stoner C
J Med Chem; 2011 Jun; 54(12):4219-33. PubMed ID: 21557540
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characteristics of a novel nonthiazolidinedione insulin sensitizer, FK614.
Minoura H; Takeshita S; Ita M; Hirosumi J; Mabuchi M; Kawamura I; Nakajima S; Nakayama O; Kayakiri H; Oku T; Ohkubo-Suzuki A; Fukagawa M; Kojo H; Hanioka K; Yamasaki N; Imoto T; Kobayashi Y; Mutoh S
Eur J Pharmacol; 2004 Jun; 494(2-3):273-81. PubMed ID: 15212984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
